X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
psychopharmacological treatment (201) 201
psychiatry (181) 181
humans (179) 179
male (94) 94
pharmacology & pharmacy (82) 82
double-blind (81) 81
female (70) 70
clinical neurology (68) 68
adult (64) 64
neurosciences (59) 59
treatment outcome (48) 48
depression (46) 46
adolescent (43) 43
schizophrenia (43) 43
comorbidity (40) 40
social phobia (40) 40
phobic disorders - drug therapy (39) 39
placebo (39) 39
animals (38) 38
antidepressants (36) 36
child (33) 33
psychotropic drugs - therapeutic use (33) 33
serotonin uptake inhibitors - therapeutic use (33) 33
children (32) 32
pharmacotherapy (31) 31
bipolar disorder (30) 30
mental disorders (30) 30
phenelzine (30) 30
antipsychotic agents - therapeutic use (29) 29
middle aged (29) 29
monoamine oxidase inhibitors - therapeutic use (27) 27
psychology, clinical (27) 27
psychopharmacological agent (27) 27
fluoxetine (26) 26
phobic disorders - psychology (26) 26
adolescents (25) 25
antidepressive agents - therapeutic use (25) 25
drug therapy (25) 25
rats (25) 25
anxiety (24) 24
paroxetine (24) 24
efficacy (23) 23
prevalence (23) 23
psychotherapy (23) 23
serotonin (23) 23
drugs (22) 22
moclobemide (22) 22
psychotropic drugs (22) 22
research (22) 22
controlled trial (21) 21
dose-response relationship, drug (21) 21
panic disorder (21) 21
psychiatric status rating scales (21) 21
brofaromine (20) 20
care and treatment (20) 20
sertraline (20) 20
aged (18) 18
asenapine (18) 18
mental disorders - drug therapy (18) 18
placebo-controlled trial (18) 18
psychiatric-disorders (18) 18
psychology (18) 18
psychopharmacological drugs (18) 18
psychopharmacology (18) 18
antipsychotic agents - pharmacology (17) 17
anxiety disorder (16) 16
drug administration schedule (16) 16
phobic disorders - diagnosis (16) 16
analysis (15) 15
antipsychotics (15) 15
behavior (15) 15
double-blind method (14) 14
phobia (14) 14
psychotropic drugs - adverse effects (14) 14
serotonin reuptake inhibitors (14) 14
antipsychotic-drugs (13) 13
benzodiazepines - therapeutic use (13) 13
dopamine (13) 13
health aspects (13) 13
heterocyclic compounds, 4 or more rings - pharmacology (13) 13
medicine, general & internal (13) 13
psychopharmacological intervention (13) 13
anti-anxiety agents - therapeutic use (12) 12
anxiety disorders (12) 12
benzodiazepines (12) 12
bipolar disorder - drug therapy (12) 12
child, preschool (12) 12
clinical trials (12) 12
clinical trials as topic (12) 12
medicine & public health (12) 12
mental retardation (12) 12
neuroleptics (12) 12
obsessive-compulsive disorder (12) 12
olanzapine (12) 12
pediatrics (12) 12
psychopharmacological interventions (12) 12
social anxiety disorder (12) 12
aged, 80 and over (11) 11
antipsychotic agents - adverse effects (11) 11
antipsychotic drugs (11) 11
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (327) 327
German (41) 41
French (8) 8
Russian (5) 5
Spanish (4) 4
Portuguese (3) 3
Turkish (2) 2
Dutch (1) 1
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2002, Innovations in practice and service delivery with vulnerable populations, ISBN 9780195134575, x, 390
Book
Journal of the American Academy of Child and Adolescent Psychiatry, ISSN 0890-8567, 2016, Volume 55, Issue 1, pp. 69 - 76.e3
Objective To examine rates and predictors of receiving a psychosocial service before initiating antipsychotic treatment among young people in the Medicaid program... 
Pediatrics | Psychiatry | antipsychotic treatment | psychotherapy | access to care | children | prescribing practices | NATIONAL TRENDS | PSYCHIATRY | PSYCHOLOGY, DEVELOPMENTAL | ATYPICAL ANTIPSYCHOTICS | PROSPECTIVE COHORT | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | 2ND-GENERATION ANTIPSYCHOTICS | ADOLESCENTS | PSYCHOPHARMACOLOGICAL TREATMENT | DOUBLE-BLIND | PEDIATRICS | FOSTER-CARE | Medication Adherence - statistics & numerical data | Health Services Accessibility - statistics & numerical data | United States | Humans | Child, Preschool | Infant | Logistic Models | Male | Practice Patterns, Physicians | Young Adult | Antipsychotic Agents - therapeutic use | Mental Disorders - drug therapy | Mental Health Services | Adolescent | Adult | Female | Retrospective Studies | Medicaid | Child | Infant, Newborn | Sociodemographic aspects | Adolescence | Obsessive compulsive disorder | Neuroleptics | Demographic aspects | Hyperactivity | Bipolar disorder | Mental health care | Psychoses | Teenagers | Anxiety | Obsessive-Compulsive neuroses | Children | Adolescents | Initiation | Psychosocial factors | Psychosocial intervention | Attention deficit hyperactivity disorder | Anxiety-Depression | Attention | Bipolar affective disorder | Older children | Depression | Children & youth | Cohort analysis | Health care access
Journal Article
Adolescent health, medicine and therapeutics, ISSN 1179-318X, 2018, Volume 9, pp. 11 - 16
Journal Article
European Neuropsychopharmacology, ISSN 0924-977X, 2015, Volume 25, Issue 4, pp. 566 - 582
Abstract Antipsychotics may modulate the transcription of multiple gene programs, including those belonging to postsynaptic density (PSD) network, within... 
Internal Medicine | Psychiatry | Schizophrenia | Homer | Bipolar disorder | Asenapine | Haloperidol | Immediate-early genes | PSYCHIATRY WFSBP GUIDELINES | PSYCHIATRY | INVOLVEMENT | PSYCHOPHARMACOLOGICAL AGENT | 5-HT2A RECEPTOR | NEUROSCIENCES | CLINICAL NEUROLOGY | BIOLOGICAL TREATMENT | UPDATE 2012 | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | WORLD FEDERATION | Disks Large Homolog 4 Protein | Motor Activity - drug effects | Male | Intracellular Signaling Peptides and Proteins - metabolism | RNA, Messenger - metabolism | Corpus Striatum - metabolism | Cerebral Cortex - metabolism | Oncogene Proteins v-fos - genetics | Dose-Response Relationship, Drug | Protein Binding - drug effects | Early Growth Response Protein 1 - genetics | Homer Scaffolding Proteins | Statistics, Nonparametric | Membrane Proteins - metabolism | Post-Synaptic Density - drug effects | Cerebral Cortex - drug effects | Post-Synaptic Density - metabolism | Intracellular Signaling Peptides and Proteins - genetics | Oncogene Proteins v-fos - metabolism | AIDS-Related Complex - metabolism | Membrane Proteins - genetics | Rats | Rats, Sprague-Dawley | Gene Expression Regulation - drug effects | Carrier Proteins - genetics | Animals | Carrier Proteins - metabolism | Analysis of Variance | Corpus Striatum - drug effects | Antipsychotic Agents - pharmacology | Early Growth Response Protein 1 - metabolism | AIDS-Related Complex - genetics | Employee recruitment | Analysis
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 08/2009, Volume 18, Issue 8, pp. 1103 - 1118
Journal Article
Gastroenterology research and practice, ISSN 1687-6121, 8/2012, Volume 2012, pp. 486067 - 11
... state, it proves useful to encourage psychopharmacological treatments and psychosocial therapies, both aiming at reducing stress perception. The aim of this paper is to analyze the effectiveness of psychopharmacological treatment and psychological interventions on irritable bowel syndrome. 
CORTICOTROPIN-RELEASING-FACTOR | CLINICAL-TRIAL | PAROXETINE CONTROLLED-RELEASE | COGNITIVE-BEHAVIOR THERAPY | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | DIARRHEA-PREDOMINANT | DIAGNOSTIC-CRITERIA | GASTROENTEROLOGY & HEPATOLOGY | FUNCTIONAL GASTROINTESTINAL DISORDERS | COLONIC DISTENSION | Psychological aspects | Care and treatment | Usage | Psychopharmacology | Irritable bowel syndrome | Psychotherapy | Research | Health aspects | Review
Journal Article
The international journal of neuropsychopharmacology, ISSN 1461-1457, 2015, Volume 18, Issue 3, pp. pyu068 - pyu068
Journal Article